{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T01:39:14Z","timestamp":1777772354686,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymgme.2023.107679","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T12:47:13Z","timestamp":1691326033000},"page":"107679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Why cystic fibrosis newborn screening programs have failed to meet original expectations\u2026 thus far"],"prefix":"10.1016","volume":"140","author":[{"given":"Philip M.","family":"Farrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107679_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijns6010008","article-title":"History of newborn screening for CF\u2014the early years","volume":"6","author":"Travert","year":"2020","journal-title":"Int. J. Neonatal. Screen"},{"key":"10.1016\/j.ymgme.2023.107679_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/gim.2014.209","article-title":"Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study","volume":"18","author":"Baker","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ppul.26253","article-title":"Refinement of newborn screening for cystic fibrosis with next generation sequencing","volume":"58","author":"Rock","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2023.107679_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/ijns7040073","article-title":"Validation of a custom next generation sequencing assay for cystic fibrosis newborn screening","volume":"7","author":"Sicko","year":"2021","journal-title":"Int. J. Neonatal. Screen"},{"key":"10.1016\/j.ymgme.2023.107679_bb0025","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/ppul.25658","article-title":"Outcomes of infants born during the first 9 years of CF newborn screening in the United States: a retrospective Cystic Fibrosis Foundation patient registry cohort study","volume":"56","author":"Martiniano","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2023.107679_bb0030","article-title":"Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening","volume":"22","author":"McColley","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymgme.2023.107679_bb0035","doi-asserted-by":"crossref","first-page":"113595","DOI":"10.1016\/j.jpeds.2023.113595","article-title":"Late diagnosis through newborn screening negatively effects short- and long-term growth and pulmonary health outcomes in infants with cystic fibrosis","author":"Martiniano","year":"2023","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107679_bb0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ppul.26209","article-title":"Detection of disease-causing CFTR variants in state newborn screening programs","volume":"58","author":"McGarry","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2023.107679_bb0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2015-0811","article-title":"California cystic fibrosis newborn screening consortium. Newborn screening for cystic fibrosis in California","volume":"136","author":"Kharrazi","year":"2015","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgme.2023.107679_bb0050","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jpeds.2005.08.016","article-title":"Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes","volume":"147","author":"P.W. 3rd, Campbell, T.B. White.","year":"2005","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107679_bb0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/ajcn\/54.3.578","article-title":"Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention","volume":"54","author":"Marcus","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2023.107679_bb0060","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1542\/peds.72.5.741","article-title":"Neonatal screening for cystic fibrosis: position paper","volume":"72","author":"Taussig","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2023.107679_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.107.1.1","article-title":"Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin cystic fibrosis neonatal screening study group","volume":"107","author":"Farrell","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2023.107679_bb0075","series-title":"Newborn Screening for Cystic Fibrosis: Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs, Morbidity and Mortality Weekly Report, Recommendations and Reports","first-page":"1","author":"Grosse","year":"2004"},{"key":"10.1016\/j.ymgme.2023.107679_bb0080","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR Potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0085","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ppul.26279","article-title":"Variation in cystic fibrosis newborn screening algorithms in the United States","volume":"58","author":"Rehani","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2023.107679_bb0090","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamapediatrics.2022.2674","article-title":"Real-world associations of US cystic fibrosis newborn screening programs with nutritional and pulmonary outcomes","volume":"176","author":"Rosenfeld","year":"2022","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.ymgme.2023.107679_bb0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM199109123251104","article-title":"Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations","volume":"325","author":"Hammond","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.85.6.1001","article-title":"Newborn screening for cystic fibrosis is complicated by age-related decline in Immunoreactive trypsinogen levels","volume":"85","author":"Rock","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2023.107679_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X","article-title":"The incidence of cystic fibrosis","volume":"15","author":"Kosorok","year":"1996","journal-title":"Stat. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0110","article-title":"Improving the rate of sufficient sweat collected in infants referred for sweat testing in Michigan","volume":"1","author":"Abdulhamid","year":"2014","journal-title":"Glob. Pediatr. Health"},{"key":"10.1016\/j.ymgme.2023.107679_bb0115","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jpeds.2016.09.065","article-title":"Diagnosis of cystic fibrosis in screened populations","volume":"181S","author":"Farrell","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107679_bb0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3476(83)80653-2","article-title":"Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants","volume":"102","author":"Wilcken","year":"1983","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107679_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns6010018","article-title":"Newborn screening for CF across the globe\u2014where is it worthwhile?","volume":"6","author":"Scotet","year":"2020","journal-title":"Int. J. Neonatal. Screen"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107679_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2012.02.013","article-title":"Immunoreactive trypsinogen (IRT) as a biomarker for cystic fibrosis: challenges in newborn dried blood spot screening","volume":"106","author":"Therrell","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107679_bb0135","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1542\/peds.2008-1681","article-title":"Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen","volume":"123","author":"Kloosterboer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2023.107679_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ymgme.2021.08.005","article-title":"Improving outcomes for Colorado\u2019s IRT-IRT-DNA cystic fibrosis newborn screening algorithm by implementing floating cutoffs","volume":"134","author":"Martiniano","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107679_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ijns8040058","article-title":"Missed cystic fibrosis newborn screening cases due to immunoreactive trypsinogen levels below program cutoffs: a National Survey of risk factors","volume":"27","author":"Kharrazi","year":"2022","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2023.107679_bb0150","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2023.107679_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00125817-200103000-00010","article-title":"Laboratory standards and guidelines for population based cystic fibrosis carrier screening","volume":"3","author":"Grody","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.GIM.0000139506.11694.7C","article-title":"Cystic fibrosis population carrier screening: 2004 Revision of American College of Medical Genetics mutation panel","volume":"6","author":"Watson","year":"2004","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0165","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1542\/peds.2006-1993","article-title":"Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report","volume":"119","author":"Comeau","year":"2007","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgme.2023.107679_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpedi.155.2.117","article-title":"Is public health ready for genetics?","volume":"155","author":"Holtzman","year":"2001","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ymgme.2023.107679_bb0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/archdischild-2020-318999","article-title":"Cystic fibrosis newborn screening: the importance of bloodspot sample quality","volume":"106","author":"Doull","year":"2021","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2023.107679_bb0180","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ppul.21509","article-title":"Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening","volume":"46","author":"Rock","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2023.107679_bb0190","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/bmj.302.6787.1237","article-title":"Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis","volume":"302","author":"Ranieri","year":"1991","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ymgme.2023.107679_bb0195","first-page":"616","article-title":"Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols","volume":"52","author":"Gregg","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107679_bb0200","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1542\/peds.99.6.819","article-title":"Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods","volume":"99","author":"Gregg","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2023.107679_bb0205","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF00197409","article-title":"Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses","volume":"96","author":"F\u00e9rec","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107679_bb0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ppul.21561","article-title":"Estimating the annual number of false negative cystic fibrosis newborn screening tests","volume":"47","author":"Fritz","year":"2012","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2023.107679_bb0215","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jpeds.2009.03.057","article-title":"A new cystic fibrosis newborn screening algorithm: IRT\/IRT1 upward arrow\/DNA","volume":"155","author":"Sontag","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107679_bb0220","series-title":"Newborn Screening for Cystic Fibrosis: Guideline","author":"CLSI","year":"2011"},{"key":"10.1016\/j.ymgme.2023.107679_bb0225","series-title":"Newborn Screening for Cystic Fibrosis","author":"CLSI","year":"2019"},{"key":"10.1016\/j.ymgme.2023.107679_bb0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijns9020020","article-title":"Implementation of newborn screening for conditions in the United States first recommended during 2010\u20132018","volume":"9","author":"Singh","year":"2023","journal-title":"Int. J. Neonatal. Screen"},{"key":"10.1016\/j.ymgme.2023.107679_bb0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.24316","article-title":"Cystic fibrosis newborn screening: a model for neuromuscular disease screening?","volume":"77","author":"Scully","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107679_bb0240","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/medethics-2012-101019","article-title":"Two faces of patient advocacy: the current controversy in newborn screening","volume":"40","author":"Arnold","year":"2014","journal-title":"J. Med. Ethics"},{"key":"10.1016\/j.ymgme.2023.107679_bb0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/humu.22927","article-title":"Clinical sensitivity of cystic fibrosis mutation panels in a diverse population","volume":"37","author":"Hughes","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2023.107679_bb0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ijns1010013","article-title":"The newborn screening quality assurance program at the Centers for Disease Control and Prevention: thirty-five year experience assuring newborn screening laboratory quality","volume":"1","author":"De Jes\u00fas","year":"2015","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2023.107679_bb0255","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1542\/peds.113.6.1573","article-title":"Population-based newborn screening for genetic disorders when multiplemutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections","volume":"113","author":"Comeau","year":"2004","journal-title":"Pediatrics"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:55:28Z","timestamp":1761090928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223003098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1096719223003098"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107679","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why cystic fibrosis newborn screening programs have failed to meet original expectations\u2026 thus far","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107679"}}